Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP

RegulatoryapprovedModafinil Tablets, USPPositive

AI Analysis

Summary

Lupin Limited announced U.S. FDA approval for Modafinil Tablets, USP, a generic pharmaceutical product. This regulatory approval represents a market-moving milestone for the company's product portfolio in the United States.

Outcome Details

U.S. FDA approval for Modafinil Tablets, USP

Importance:8/10

Sentiment:

0.85

FDA approvalgeneric drugregulatory

Related Companies

$GBCYD $UTHR

Read the original article

Published by PR Newswire Pharma on September 4, 2026 5:42 PM

Read Original